title: Noninvasive Submental Fat Compartment Treatment.
abstract: BACKGROUND
  KYBELLA, ATX-101, is an injectable form of sodium deoxycholic acid. It is currently the only Food and Drug Administration-approved injectable drug for the reduction of submental fat.
  
  
  OBJECTIVE
  A literature review and discussion of the treatment of submental fat.
  
  
  RESULTS
  KYBELLA is a well-tolerated alternative for the treatment of submental fat.
  
  
  CONCLUSIONS
  KYBELLA is a safe and efficacious, first in class, injectable drug for the reduction of submental fat.
authors.affiliation: private practice, Ava MD, Beverly Hills and Santa Monica, Calif.
authors.forename: Ava T
authors.initials: AT
authors.lastname: Shamban